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BACKGROUND: Adverse drug reactions account for the highest proportion among the causes of 
morbidity and mortality in clinical wards and are posing a considerable challenge. Hence, the objective 
of this study was to find out the prevalence of adverse drug reactions and the factors which contribute to 
their prevalence.  
METHODS: A prospective patient record review was carried out at a tertiary care hospital in North India 
from August 2010- May 2011. A total of 1033 subjects admitted to hospital for any kind of treatment were 
included while patients admitted in the ward because of adverse drug reactions were excluded. The ward 
where we collected the data includes multispecialty and cardiovascular wards. The causality, severity, 
and preventability of adverse drug reactions were assessed using Naranjo, modified Hartwig, and 
Schumock and Thornton criteria, respectively. Kolmogorov–Smyrnov, chi –square and multiple logistic 
regression tests were used to determine adverse drug reactions ascribed to drugs.  
RESULTS: Out of 1033 patients whose records were assessed, 167(16.2%) experienced one or more 
adverse drug reactions. The metabolic systems, which accounted for 49(24.6%) were most frequently 
affected by adverse drug reactions, followed by gastrointestinal, 45(22.6%); hematological, 28(14.1%) 
and cutaneous, 21(10.6%) systems. The drug classes most frequently associated with the reactions were 
antibiotics 40(20.1%), diuretics 35(17.6%) and anticoagulants 30(15.1%). According to the selected 
preventability scale, 72(36.2%) adverse drug reactions were classified as probably or definitely 
preventable. About 165(83%) of the reactions were type A, which represents augmentation of the 
pharmacological action of a drug. Number of drugs, length of hospitalization and number of diagnosis 
were identified as significant predisposing factors for ADRs. 
CONCLUSION: The result of this study suggested that adverse drug reactions were significant causes of 
superimposed health problems that occur following hospitalization. The major risk factors associated 
with ADR include number of drugs, length of hospitalization and number of diagnosis. Based on the 
findings a rigorous study is recommended to determine the burden and identify the risk factors of adverse 
drug reactions to target interventions. 
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INTRODUCTION                                                                                                  
 
Adverse drug reactions are the most frequently 
reported causes of morbidity and mortality during 
hospitalizations (1), affecting up to 20% of all 
hospitalized patients in many countries and 
becoming an important challenge in today's 
modern medicine in terms of early recognition, 
proper management and their prevention (2, 3, 4). 
A meta-analysis made by Lazarou et al. (1998) to 
assess 39 American studies showed that the rate of 
serious and fatal ADRs were 6.7% and 0.3%, 
respectively (1).  
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The same authors reported that ADRs ranked 
between the fourth and sixth leading causes of 
death in the USA. In India, very few studies 
were conducted 5 to 10 years ago and looked at 
ADRs as the cause of hospital admissions. A 
study carried out in a tertiary referral center in 
Mumbai indicated that ADRs were responsible 
for 6.9% of total admissions (5). This author 
reported that deaths due to ADRs accounted for 
0.8%. These days, ADR is a known cause of 
morbidity and mortality after hospitalization in 
different countries of the world (3, 4, 6).  
Despite the relevance of this, there is no 
available data regarding the characteristics and 
the incidence of ADRs among hospitalized 
patients, in India. One study conducted on 
hospitalized patients by Jose et al. (2006) (7)
 
in 
Karnataka showed that the overall incidence of 
ADR calculated from the patient population was 
only 0.15%. The reason for this low incidence 
was that information on the ADRs was collected 
only if physicians reported through the 
spontaneous reporting system. More recent data 
are thus needed to determine the actual 
incidence of ADRs after admission to hospital. 
Therefore, this study aimed at obtaining more 
recent and accurate data on the prevalence of 
ADRs among hospitalized patients and 
ascertaining their contributing factors. 
 
SUBJECTS AND METHODS 
 
This study was carried out in wards of a tertiary 
care hospital in northern India from August 
2010-May 2011. This hospital is one of the 
largest private health facilities. The hospital was 
founded in 2001 and includes multispecialty and 
super specialty in heart. It has 7 operational 
theatres, 215 operational beds for inpatients with 
installed capacity for up to 300 beds. The 
hospital has standard multispecialty and 
cardiovascular wards from which the data was 
collected. 
All patients admitted to the wards were 
included in the study and evaluated for ADRs. 
Only ADRs that occurred during hospital stay as 
a result of drugs initiated or continued in the 
wards were included while patients admitted to 
the hospital because of ADR were excluded. 
Intensive care units (ICUs) were excluded as the 
focus of the study was on ADRs occurring only 
among ward patients. Patient files without 
proper documentation were also excluded from 
the study. The follow up of the patients was 
done until patient discharge or transfer from 
wards to ICUs. All the information was 
collected from patients’ recorded files using a 
pre-tested data collection form. The definition of 
ADR used in this study was the one developed 
by the World Health Organization, i.e. “all the 
noxious and unintended drug responses which 
occur at doses normally used in man for the 
prophylaxis, diagnosis, or therapy of disease, or 
for the modification of physiological function” 
(8). In identification of ADRs, objective criteria 
that involve changes in laboratory values and 
vital signs which are not related to the disease 
pathology and subjective criteria which include 
increase in severity of symptoms or appearance 
of new symptoms were identified as an ADR 
from patients’ record file as well as from the 
physicians and nurses notes. Additionally, 
ADRs from patients’ charts that were identified 
by physicians or nurses were also included in the 
study. For validation, ADRs were discussed and 
confirmed with the clinical pharmacologist of 
the hospital after they were identified and 
assessed for causality, severity and 
preventability. 
The assessment of causality was then 
performed for all the cases using the Naranjo's 
algorithm (9). The severity of ADRs was 
determined by using the modified Hartwig 
criteria (10) as described in Table 1, while the 
preventability of ADRs was assessed by using 
the modified Schumock and Thornton criteria 
(11). ADRs were also classified as either type A 
(dose-dependent and predictable from the known 
pharmacology) or type B (idiosyncratic, no clear 
dose response relationship, and not predictable 
from the known pharmacology) according to the 
system introduced by Rawlins and Thompson 
(12). Drugs were categorized according to the 
Anatomical Therapeutic and Chemical (ATC) 
classification system (13), and ADRs were 
coded according to the MedDRA terminology 
(14). 
Statistical analysis: The Kolmogorov–Smyrnov 
test was used to determine the distribution of 
variables. Approximately, normally distributed 
variables were summarized using mean and 
standard error of mean (mean ± SEM) while 




variables without normal distribution were 
summarized using the median, the lower (Q1) 
quartile, and upper (Q3) quartile. Chi-square test 
was applied for comparing categorical variables 
and multiple logistic regression with 95% 
confidence interval was calculated to observe 
relationships of predisposing factors for ADRs. 
P-value below 0.05 was considered as 
significant. All the analyses were performed 
using the statistical software sigma stat version 
3.5. 
This study was approved by Institutional 
Ethics Committee and by the Hospital. Patients’ 
written informed consent to participate in the 
study was obtained after comprehensive 
explanation of the purpose and procedure of the 
study. During the data collection, the patients at 
any risk of complication of adverse reactions 
were treated at spot after the response was taken. 
To ensure confidentiality, any attempt to collect 
information that would expose the identity of 




The results were based on data collected from 
the records of 1033 patients (590 males, 443 
females) taken from different inpatient wards. 
Of those patients used in the study, 167 (16.2%) 
experienced at least one ADR. Among those, 
144 patients experienced only one ADR whilst 
23 patients had more than one ADR: 
encountered simultaneously or successively, 
totaling up to 199 ADRs. The highest number of 
ADR observed in a single patient was four. 
About 9% of ADRs were caused by a 
combination of two or more drugs leading to the 
same ADR. No statistically significant 
difference was observed in the incidence of 
ADRs in both males and females (X
2
 = 1.38, p = 
0.24), and the incidence of ADRs among 
different age groups was also not statistically 
significant (X
2
 = 3.18, p = 0.2). More patients 
admitted to the cardiovascular ward experienced 
ADRs (n = 54, 21.8%) than those who were in 
the multispecialty ward (n = 113, 14.4%) (X
2 
= 
7.037, p < 0.05). From multivariate analysis, the 
only significant indicators for the occurrence of 
ADRs observed in this study were the number of 
drugs [OR: 1.1 (1.06-1.14), p < 0.001], length of 
hospitalization [OR: 1.1 (1.04-1.14), p < 0.001], 
and number of diagnosis [OR: 1.22 (1.06-1.4), p 
< 0.05]. The median length of hospitalization 
was 7 days (Q1–Q3 = 5-8 days, range = 2–37 
days). The median age of patients was 61 years 
(Q1-Q3 = 49-68.3 years, range = 1-98 years). 
The top ten diagnoses of patients admitted 
included: hypertension 318 (13.6%), 
osteoarthritis 215 (9.2%), coronary artery 
disease 193 (8.2%), type-2 diabetes mellitus 177 
(7.6%), hypothyroidism 56 (2.4%), cancer 48 
(2%), fracture 38 (1.6%), urinary tract infection 
30 (1.3%), dengue fever 27 (1.2%) and sepsis 26 
(1.1%). 
 
Table 1: The modified Hartwig’s severity classification 
 
Level                                      Description Grade 
1 An ADR occurred but no change in treatment with suspected drug  Mild 
2 The ADR required that treatment with the suspected drug be held, discontinued, 
or otherwise changed. No antidote or other treatment required. No increase in 
length of stay  
Mild 
3 The ADR required that treatment with the suspected drug be held, discontinued, 
or otherwise changed, and/or an antidote or other treatment. No increase in length 
of stay  
Moderate 
4 Any Level 3 ADR which increases length of stay by at least one day or the ADR 
was the reason for admission  
Moderate 
5 Any level 4 ADR which requires intensive medical care  Severe 
6 The ADR caused permanent harm to the patient  Severe 
7a The ADR was indirectly linked to death of patient  Severe  
7b The ADR was directly linked to death of patient  Severe 
 




The nature of the ADRs and the drugs mostly 
involved are presented in Table 2. Metabolic 
ADRs were the most frequent, 49 (24.6%), 
followed by gastrointestinal ADRs, i.e. 45 
(22.6%), hematological ADRs, 28 (14.1%), and 
cutaneous ADRs making 21 (10.6%). The most 
prevalent metabolic ADR was hypokalemia, 34 
(69.4%), mainly due to diuretics, 25 (73.5%).  
None of the ADRs identified were new 
(unlabelled).The drugs associated with the 143 
(72%) identified ADRs were clustered in a few 
therapeutic classes. Cardiovascular agents were 
responsible for 53 (26.6%) of all ADRs followed 
by antibiotics, 40 (20.1%), anticoagulants, 30 
(15.1%), and opioids, 21 (10.6%). All the other 
classes accounted for 30% of the ADRs. The 
summary of classes of drugs responsible for 

























Figure 1. ATC based classification of drugs involved in ADR 
 
Using the Naranjo algorithm for causality 
assessment, 143 (71.9%) ADRs were identified 
as probable, 52 (26.1%) as possible, and 4 (2%) 
as definite due to re-challenge or due to the fact 
that the patient’s ADR history to the same drug 
or cross reactivity. By using the modified 
Schumock and Thornton’s criteria, 14 (7%) of 
the reactions were classified as definitely 
preventable, 58 (29.2%) were probably 
preventable while 127 (63.8%) were recognized 
to be not preventable at all. 
Using modified Hartwig’s classification it 
was found out that out of 199 ADRs, 95 (47.7%) 
were identified as mild, 89 (44.7%) as moderate 
and 15 (7.5%) as severe. A greater proportion of 
ADRs, 160 (80.4%), required some intervention 
(ranging from stopping the causative drug to 
initiation of other treatments like oral 
vancomycin or metronidazole for the treatment 
of antibiotic related diarrhea) but did not 
increase the length of stay (i.e. level 2 and 3) 
(Table 1). However, from analysis of records, 19 
(9.5%) reactions were observed to have had an 
impact on the length of stay and were thus 








Table 2: Description of systems affected, drugs involved, and ADRs of Ward patients in the Tertiary Care Hospital in the Northern India from 
August 2010-May 2011 
 
System Drug (number) ADR (number) 
Metabolic  Diuretics (30) Hypokalemia (25), hyponatremia (5) 
Systemic  corticosteroids (6) Hypokalemia (4), hyperglycemia (2) 
Antidiabetes (6) Hypoglycemia (5), hypokalemia 
Salbutamol (2)/calcium gluconate/fluconazole hypokalemia (4) 
ARBs (2)/ACEi Hyperkalemia (3) 
Gastrointestinal Opioids (15) Vomiting (8), nausea (5), constipation (2) 
Antibiotics (10)/anti-parasitics (2)/ Pyrazinamide (2) Diarrhea (4), clostridium dificile infection (4), vomiting (3), 
constipation, anorexia, dryness of mouth 
Laxatives (8) Diarrhea (8) 
Aspirin (3)  GI bleeding (3) 
NSAIDs (5) Gastritis (4), epigastric pain 
Hematological Anticoagulants (17) Thrombocytopenia (14), increased INR (3) 
Antibiotics (9) Thrombocytopenia (5), pancytopenia (3), anemia 
NSAID/anti-neoplastics Leukepenia, pancytopenia 
Cutaneous  Antibiotics (14) Rash (13), swelling around the eye 
NSAID/paracetamol/ondansetron/allopurinol Rash (4) 
NSAID/acenocoumarol/warfarin Angioedema, facial puffiness, ecchymosis 
CNS Anti-psychotics (6) Drowsiness (4), extrapyramidal symptoms, sedation 
Opioids (5) Restlessness (3), drowsiness, psychosis  
Systemic corticosteroids (2) Delirium (2) 
Aspirin + enoxaparin/Salbutamol/metoclopramide Intracranial bleeding, tremors, extrapyramidal symptoms 
Cardiovascular Β-blockers (5) Hypotension (3), bradycardia (2) 
Ca 
+2
 channel blockers + β- blockers (3)/diuretics 
(2)/ACEi + diuretic/Ca
+2
 channel blocker + diuretic/ARB 
+ diuretic 
Hypotension (8) 
Amiodarone/hyoscine/terlipressin Bradycardia (3) 
Renal Anticoagulants (9) Haematuria (9) 
 Antibiotics (6) Increased serum creatinine (3), acute interstitial nephritis, urinary 
retention, worsening of renal function  
Respiratory ACEi (2) Dry cough (2) 
Polymyxin B/tramadol/metoprolol Apnea, respiratory depression, bronchospasm 
Endocrine Amiodarone (2) Hypothyroidism (2) 
Sensory Amikacin/nitroglycerin Visual impairment, tingling sense 
Hepatic Isoniazid Increased liver enzymes 
Muscular Prednisolone Osteoporosis 
*
CNS, central nervous system; NSAIDs, non-steroidal anti-inflammatory drugs; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor 
blockers; GI, gastrointestinal; INR, international normalized ratio; Numbers in the parenthesis indicate frequency and single frequency wasn’t indicated
*
 




None of the ADRs resulted in death or permanent 
damage. However, 15 ADRs, for example acute 
delirium due to methyl prednisolone, acute 
interstitial nephritis due to amoxicillin, severe 
hypotension due to antihypertensive drugs, and 
respiratory depression due to tramadol were 
considered as severe that led to admission to 
intensive care units. Type A reactions accounted 
for 165 (82.9%) of the ADRs while 34 (17.1%) 




The overall prevalence of ADRs in this study was 
found to be 16.2%, which is consistent with the 
range of results from recent prospective studies in 
hospitalized patients which used a similar 
methodology as the present study (1, 4, 6). 
However, the figure in this study is higher than 
3.7% and 6.9% incidences which were observed 
in a prospective study by Ramesh et al. (2003) 
(15) and Patel et al. (2007) (5), carried out in a 
tertiary referral center in South India and 
Mumbai, respectively. The findings of the study 
conducted by Jose et al. (2006) (7) in Karnataka, 
India showed a prevalence of 0.15% only. This is 
because this study used spontaneous reporting 
system as the only method for detecting ADRs. 
In the present study, ADRs were identified by 
prospective manner using patient chart as source 
of information (medical and nursing notes, 
laboratory diagnosis data) combined with 
spontaneous reporting. The most frequently 
encountered ADRs in this study were found to be 
metabolic ADRs (Table 2). Diuretics were the 
most prevalent drugs responsible for metabolic 
ADRs during hospitalization affecting, especially 
the elderly patients with a high degree of 
utilization of these drugs. This finding is 
consistent with the results of another study which 
included a population of elderly people (2, 16).  
 In contrast with the results of other studies 
which detected gastrointestinal ADRs up to a 
proportion of 31.3% (17) and 17.9% (2), in the 
present study gastrointestinal ADRs were the 
second most frequently manifested cases 
accounting for 22.6% of all ADRs. The majority 
of these ADRs were moderate symptoms like 
diarrhea and vomiting. There were only three 
cases of GI bleeding induced by aspirin. NSAIDs 
were responsible for ADRs like gastritis and 
epigastric pain. 
 In our present study, hematological and 
cutaneous reactions were the third and fourth 
most frequently manifested ADRs accounting for 
14.1% and 10.6% of all ADRs, respectively. This 
observation is consistent with the study 
conducted in India by Jose et al. (2006) (7) who 
reported cutaneous reactions as the most frequent 
ones. A study conducted in a teaching hospital in 
Taiwan also reported cutaneous and 
hematological reactions as the most frequently 
manifested ADRs (18).   
 Recent studies conducted on hospitalized 
patients reported antibiotics, diuretics, and anti-
diabetics as drugs most frequently linked to 
ADRs. NSAIDs and opioids have been 
implicated, particularly in studies involving 
surgical patients with diuretics being prevalent as 
causative factors in elderly patients (19). Studies 
that were conducted in India showed anti-
neoplastics 89 (21.8%) (7)
  
and antibiotics 55 
(33.5%) (20); as the drug classes to cause most of 
the ADRs. Similar to results obtained by other 
investigators, the result of our study showed a 
high percentage of ADRs in patients taking 
antibiotics, accounted for 20.1% of all ADRs. 
Similarly, a research carried out in Spain by 
Carrasco-Garrido et al. (2010) (21) revealed that 
22.1% of ADRs were associated with antibiotics. 
In Italy, Trifiro et al. (2005) (22) studied the 
incidences of ADRs and ADR related hospital 
admissions  from emergency visits and found that 
antibiotics were associated with 12.9% of ADRs. 
Diuretics and anticoagulant drugs were the next 
most common drugs responsible for ADRs, 
accounting for 16.1% and 15.1%, respectively. 
  The findings of this study were in 
accordance with recent studies in which there 
was a high prevalence of older patients with 
cardiovascular disease (23, 24). Furosemide 23 
(11.6%) and tramadol 21 (10.6%) were the 
individual drugs to cause the majority of the 
ADRs. A previous unpublished thesis study 
conducted in 2010 by  Immaculich Rani in the 
same setting indicated that cardiovascular agents, 
89 (24.7%), followed by antibiotics, 66 (18.3%), 
and anti-coagulants, 51 (14.2%), were the chief 
groups of drugs in causing ADRs while 
furosemide and tramadol as the individual drugs 
to cause most of the ADRs. Common use of these 




two drugs in the study hospital could be a good 
reason for these observed ADRs. Antibiotics 
were also among the most frequently prescribed 
drug classes in the hospital. Therefore, this 
excessive use of antibiotics was also responsible 
for an increased risk of ADRs. 
 According to the result of our study, type A 
reactions accounted for 82.9% of the ADRs while 
17.1% ADRs were of type B. This was in 
agreement with the definition of type A reactions 
that are more common and predictable and type 
B reactions that are rare and uncommon. 
Moreover, our results were consistent with the 
reports of studies carried out in Karnataka, India
 
and Liverpool, UK. In those reports, type A 
ADRs were found to be 72.5% (7) and 94.1% (6), 
respectively. The largest frequency of ADRs was 
very common in the females and has been 
described in various reports (19, 25). Wiffen et 
al. (2002) in their review identified gender to be 
a risk factor for development of ADR (26). 
Edwards et al. (2000) also reported that women 
were more susceptible to ADRs than men 
possibly by an association of factors such as 
greater concentration of adipose tissue and 
hormonal determinants that can affect 




In contrast, no significant difference was 
seen in the incidence of ADRs observed in male 
and female in the present study. Though the 
difference was not statistically significant in 
pediatric and adult population, relatively the 
highest percentage of ADRs was observed in 
elderly patients. Those groups of population also 
took more medications as compared to others to 
manage a number of co-morbidities associated 
with increase in age (28). Our findings were also 
in agreement with several studies. For instance, 
in a study conducted in Karnataka, India (7), the 
incidence of ADRs among elderly patients was 
significantly higher than among patients of other 
age groups.
 
Similarly, a prospective study carried 
out in Punjab also showed that elderly patients 
had a higher incidence of ADRs (29). Studies 
conducted in England (30) also supported our 
observations. A retrospective study conducted in 
Australia also showed that elderly patients had a 
significantly higher incidence of ADR as 
compared to other age groups (31). 
 A significant association was observed 
between the length of hospitalization of a patient 
and the prevalence of ADRs in the present study 
(p < 0.001). Patients with longer stay in the 
hospital had more severe conditions, many co-
morbid conditions and used a higher dose of 
different drugs. Therefore, patients with longer 
hospital stay were more prone to develop ADRs. 
There was also a definite association between 
ADRs and increased length of stay found out by 
several studies. A study conducted by Davies et 
al.(2006) in Royals Liverpool Hospital also 
indicated an increase in the incidence of ADRs 
with increased length of hospital stay (6). Similar 
study conducted in south India also reported that 
an increase in the incidence of ADRs as the 
length of stay of the patient increased (7). The 
number of diagnosis was found to be a significant 
predisposing factor for ADRs in the present study 
multiplying the risk by 1.2 with each additional 
diagnosis. Patients with more co-morbid 
conditions are always at a higher risk of 
developing ADRs. As found out in the present 
study, the majority of the patients admitted to the 
target hospital had hypertension and diabetes 
mellitus as co-morbidities. Those diseases could 
be attributed to impairment of renal function 
which was an important factor for increasing risk 
of ADRs, and also using a higher number of 
drugs to treat the multiple diseases could result in 
ADRs. The result of our study was also in a 
complete agreement with two studies conducted 
by Jose et al. (2006) (7) and Hardmeier et al. 
(2004) (32), which identified number of 
diagnosis as one of the most predisposing risk 
factors for having ADRs. 
 Many studies have shown that patients 
taking more medications suffer from ADRs (17, 
24).
 
Likewise, the present study also revealed 
number of drugs as a significant risk factor for 
ADRs with each additional medication 
multiplying the risk of an ADR episode by 1.1 
(95% CI 1.06, 1.14). The possible reasons for this 
fact could be the prescription of multiple drugs 
which increase the risk of drug-drug interactions 
and additive or overlapping effects of multiple 
medications. Since the hospital selected for this 
study was a cardiac with multi-specialties, the 
majority of the patients admitted were with a 
number of co-morbidities which could result in 




polypharmacy that lead to the occurrence of 
ADRs. A study conducted by Davies et al. (2006) 
in Royal Liverpool University Hospital also 
reported a similar finding to this study with a 
hazard ratio of 1.14 (95% CI 1.09, 1.20) (6). 
 In this study, cardiovascular ward had a 
higher incidence of ADRs than multispecialty 
ward (p < 0.05), which was similar to the 
previous unpublished thesis study conducted by 
Immaculich Rani in the same setting in 2010. 
This was because the majority of patients 
admitted to this ward were hypertensive and 
cardiac patients with other concomitant 
morbidities such as diabetes, anemia, 
dyslipidemia and so forth which could lead to 
polypharmacy and multiple organ failure, 
increasing the chance of the occurrence of ADRs. 
Moreover, patients who were admitted to the 
cardiovascular ward were older than those who 
were in multispecialty ward.  
 As described in previous sections, ADRs 
can be classified into definitely preventable, 
probably preventable and non-preventable. A 
review by Kanjanarat et al. (2003) (33) on 
preventable ADRs in hospitals revealed a 
preventability rate of 35.2%, while the present 
study indicated a preventability rate of 36.2% 
that was almost comparable with the former. 
In conclusion, the present study showed 
that ADRs represented a significant part of 
overall medical events. In this study, antibiotics, 
diuretics, and anticoagulant agents accounted for 
more than 50% ADRs. That was a signal for a 
need for intervention and increased prevention 
level in ADR related health problems. It is 
important to note that better knowledge of 
preventable ADRs could help to design 
preventive strategies to protect patients from 
being affected by these reactions unnecessarily. 
Preventing the preventable ADRs (36.2% of the 
reactions) can result in a considerable health 
resource savings and at the same time can help 
improve the quality of health care provision. 
Therefore, we recommend further studies by 
health care professionals to accurately quantify 
the burden and to identify the risk factors of 
ADRs in hospitalized patients and to plan 
focused preventive strategies to minimize these 
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